# Clinical Study of Neoadjuvant Therapy Outcome Prediction of Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity Detection

> **NCT05767528** · — · UNKNOWN · sponsor: **Chinese PLA General Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Muscle-Invasive Bladder Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** Patient-derived tumor-like cell clusters (PTC) drug sensitivity testing

## Key facts

- **NCT ID:** NCT05767528
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-08
- **Primary completion:** 2023-12-08
- **Final completion:** 2024-12-08
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05767528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05767528, "Clinical Study of Neoadjuvant Therapy Outcome Prediction of Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity Detection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05767528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*